Conference
Efficacy and safety of Sofosbuvir/Velpatasvir for the treatment of treatment-naive, non-cirrhotic patients with chronic hepatitis C genotype 3 infection: integrated analysis of three phase 3 clinical trials
Authors
Borgia SM; Jacobson IM; Gane EJ; Weiland O; Lawitz E; Afdhal N; Cheinquer N; Wolf J; Llewellyn J; Houle S
Volume
25
Pagination
pp. 196-197
Publisher
WILEY
Publication Date
June 1, 2018
Name of conference
16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)
Conference place
Toronto, CANADA
Conference start date
June 14, 2018
Conference end date
June 17, 2018
Conference proceedings
JOURNAL OF VIRAL HEPATITIS
ISSN
1352-0504